Cryolife reported $7.06M in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2985M 750M
Atricure ATRC:US $ -10.72M 0.56M
Baxter International BAX:US $ 787M 124M
Becton, Dickinson and BDX:US $ 1182M 180M
Boston Scientific BSX:US $ 648M 407M
Cardiovascular Systems CSII:US $ -8.29M 0.07M
Cryolife CRY:US $ 7.06M 1.14M
Edwards Lifesciences EW:US $ 499.7M 19.1M
Inogen INGN:US $ 2.86M 13.47M
Integra Lifesciences IART:US $ 102.81M 9.22M
Johnson & Johnson JNJ:US $ 8036M 1273M
Mesa Laboratories MLAB:US $ 3.9M 5.38M
Natus Medical BABY:US $ 12.93M 7.6M
Pfizer PFE:US $ 12921M 1739M
Resmed RMD:US $ 294.67M 18.1M
Stryker SYK:US $ 1156M 144M
Surmodics SRDX:US $ -4.94M 2.36M
Tandem Diabetes Care TNDM:US $ -8.69M 3.02M
Teleflex TFX:US $ 191.8M 27.94M
Trinity Biotech TRIB:US 873K 928K